Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Plos One
|
September 1, 2012
Triphala and its active constituent chebulinic acid are natural inhibitors of vascular endothelial growth factor-a mediated angiogenesis
Kai Lu, Debanjan Chakroborty, Chandrani Sarkar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2004
Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis
Debanjan Chakroborty, Chandrani Sarkar, Rita Basu Mitra, et al.
The Journal of Clinical Investigation
|
March 15, 2008
Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization
Debanjan Chakroborty, Uttio Roy Chowdhury, Chandrani Sarkar, et al.
Arthritis Research & Therapy
|
November 23, 2020
Chebulinic acid is a safe and effective antiangiogenic agent in collagen-induced arthritis in mice
Kai Lu, O Hans Iwenofu, Rita Mitra, et al.
The Journal of Biological Chemistry
|
July 2, 2010
D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells
Biswarup Basu, Chandrani Sarkar, Debanjan Chakroborty, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 7, 2011
Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells
Debanjan Chakroborty, Chandrani Sarkar, Hongmei Yu, et al.
Cancer Research
|
August 18, 2004
Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis
Sujit Basu, Chandrani Sarkar, Debanjan Chakroborty, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 23, 2006
Cutting Edge: Stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation
Chandrani Sarkar, Shamik Das, Debanjan Chakroborty, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 12, 2026
Dopamine D2 Receptor Agonists as Modulators of VEGF-A-Driven Angiogenesis: Mechanisms, Clinical Evidence, and Translational Opportunities
Venu Akkanapally, Aman Kumar, Inemai Ezhil, et al.
International Immunopharmacology
|
June 18, 2003
Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells
Manik Chandra Ghosh, Amal Chandra Mondal, Sujit Basu, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Plos One
|
September 1, 2012
Triphala and its active constituent chebulinic acid are natural inhibitors of vascular endothelial growth factor-a mediated angiogenesis
Kai Lu, Debanjan Chakroborty, Chandrani Sarkar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2004
Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis
Debanjan Chakroborty, Chandrani Sarkar, Rita Basu Mitra, et al.
The Journal of Clinical Investigation
|
March 15, 2008
Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization
Debanjan Chakroborty, Uttio Roy Chowdhury, Chandrani Sarkar, et al.
Arthritis Research & Therapy
|
November 23, 2020
Chebulinic acid is a safe and effective antiangiogenic agent in collagen-induced arthritis in mice
Kai Lu, O Hans Iwenofu, Rita Mitra, et al.
The Journal of Biological Chemistry
|
July 2, 2010
D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells
Biswarup Basu, Chandrani Sarkar, Debanjan Chakroborty, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 7, 2011
Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells
Debanjan Chakroborty, Chandrani Sarkar, Hongmei Yu, et al.
Cancer Research
|
August 18, 2004
Ablation of peripheral dopaminergic nerves stimulates malignant tumor growth by inducing vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis
Sujit Basu, Chandrani Sarkar, Debanjan Chakroborty, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 23, 2006
Cutting Edge: Stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation
Chandrani Sarkar, Shamik Das, Debanjan Chakroborty, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 12, 2026
Dopamine D2 Receptor Agonists as Modulators of VEGF-A-Driven Angiogenesis: Mechanisms, Clinical Evidence, and Translational Opportunities
Venu Akkanapally, Aman Kumar, Inemai Ezhil, et al.
International Immunopharmacology
|
June 18, 2003
Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells
Manik Chandra Ghosh, Amal Chandra Mondal, Sujit Basu, et al.
Page
of 5